ES2062011T3 - Derivado de ciclohexano. - Google Patents

Derivado de ciclohexano.

Info

Publication number
ES2062011T3
ES2062011T3 ES89308062T ES89308062T ES2062011T3 ES 2062011 T3 ES2062011 T3 ES 2062011T3 ES 89308062 T ES89308062 T ES 89308062T ES 89308062 T ES89308062 T ES 89308062T ES 2062011 T3 ES2062011 T3 ES 2062011T3
Authority
ES
Spain
Prior art keywords
hetero
cycle
formula
derivative
carbamoyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89308062T
Other languages
English (en)
Inventor
Teruo Oku
Chiyoshi Kasahara
Takehiko Ohkawa
Masashi Hashimoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888819257A external-priority patent/GB8819257D0/en
Priority claimed from GB898908005A external-priority patent/GB8908005D0/en
Priority claimed from GB898909794A external-priority patent/GB8909794D0/en
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2062011T3 publication Critical patent/ES2062011T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/34—Compounds containing oxirane rings with hydrocarbon radicals, substituted by sulphur, selenium or tellurium atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

UN DERIVADO DE CICLOHEXANO DE FORMULA (I), DONDE R1 ES HALOMETILO, O ARILTIOMETILO QUE PUEDE TENER AMINO, ALCOXI INFERIOR O ACILAMINO; R2 ES ALCOXI INFERIOR; R3 ES COMPUESTO DE FORMULA: (FIG. A) O (FIG. B); Y R4 ES H, ALQUILCARBAMOILO INFERIOR, ALQUILCARBAMOILOXI INFERIOR ALQUILCARBAMOILO, CARBONILO HETEROCICLICO O CARBAMOILO HETEROCICLICO O SUS SALES. TAMBIEN SE DESCRIBE UN PROCEDIMIENTO PARA OBTENER EL DERIVADO DE CICLOHEXANO, JUNTO CON UNA COMPOSICION FARMACEUTICA QUE TIENE EL MISMO COMO INGREDIENTE ACTIVO. LOS COMPUESTOS TIENEN ACTIVIDAD INHIBIDORA DE ANGIOGENESIS Y ADEMAS SON UTILES EN EL TRATAMIENTO DE, POR EJEMPLO, TUMORES, ARTRITIS REUMATICA, RETINOPATIA DIABETICA Y SORIASIS.
ES89308062T 1988-08-12 1989-08-08 Derivado de ciclohexano. Expired - Lifetime ES2062011T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB888819257A GB8819257D0 (en) 1988-08-12 1988-08-12 Cyclohexane derivative
GB898908005A GB8908005D0 (en) 1989-04-10 1989-04-10 Cyclohexane derivative
GB898909794A GB8909794D0 (en) 1989-04-28 1989-04-28 Cyclohexane derivative

Publications (1)

Publication Number Publication Date
ES2062011T3 true ES2062011T3 (es) 1994-12-16

Family

ID=27264023

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89308062T Expired - Lifetime ES2062011T3 (es) 1988-08-12 1989-08-08 Derivado de ciclohexano.

Country Status (9)

Country Link
US (1) US4954496A (es)
EP (1) EP0354767B1 (es)
JP (1) JP2811783B2 (es)
KR (1) KR0130766B1 (es)
CA (1) CA1316921C (es)
DE (1) DE68911417T2 (es)
ES (1) ES2062011T3 (es)
HU (1) HU203543B (es)
IE (1) IE63045B1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164410A (en) * 1988-01-09 1992-11-17 Takeda Chemical Industries, Ltd. Fumagillol derivatives and pharmaceutical compositions thereof
US5180738A (en) * 1988-09-01 1993-01-19 Takeda Chemical Industries Fumagillol derivatives and pharmaceutical compositions thereof
DE68927904T2 (de) * 1988-09-01 1997-09-04 Takeda Chemical Industries Ltd Fumagillol-Derivate
US5166172A (en) * 1988-09-01 1992-11-24 Takeda Chemical Industries, Ltd. Fumagillol derivatives and pharmaceutical compositions thereof
US6017954A (en) * 1989-08-10 2000-01-25 Children's Medical Center Corp. Method of treating tumors using O-substituted fumagillol derivatives
US5290807A (en) * 1989-08-10 1994-03-01 Children's Medical Center Corporation Method for regressing angiogenesis using o-substituted fumagillol derivatives
EP0415294A3 (en) * 1989-08-31 1991-06-12 Takeda Chemical Industries, Ltd. Cyclohexanol derivatives, production and use thereof
TW282399B (es) * 1990-05-25 1996-08-01 Takeda Pharm Industry Co Ltd
DE69231457T2 (de) * 1991-06-21 2001-05-23 Takeda Chemical Industries Ltd Zyklodextrin-Zusammensetzung enthaltend Fumagillol-Derivate
ATE153854T1 (de) * 1992-12-16 1997-06-15 Takeda Chemical Industries Ltd Stabile pharmazeutische zubereitung mit fumagillolderivaten
US5710148A (en) * 1995-03-06 1998-01-20 Senju Pharmaceuticals Co., Ltd. Corneal opacification inhibitory composition
FR2733499B1 (fr) * 1995-04-27 1997-05-30 Adir Nouvelles tetrahydropyrano(3,2-d)oxazolones substituees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2733498B1 (fr) * 1995-04-27 1997-05-30 Adir Nouveaux composes cyclohexaniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DE69714230T2 (de) * 1996-03-06 2003-03-27 Tsumura & Co Neue iridoidderivate und neovaskularisations-inhibitoren die diese als aktviven inhaltstoff enthalten
US6225478B1 (en) 1997-03-05 2001-05-01 Tsumura & Co. Iridoid derivatives and neovascularization inhibitors containing the same as active ingredient
US6548477B1 (en) 2000-11-01 2003-04-15 Praecis Pharmaceuticals Inc. Therapeutic agents and methods of use thereof for the modulation of angiogenesis
US7105482B2 (en) 2000-11-01 2006-09-12 Praecis Pharmaceuticals, Inc. Methionine aminopeptidase-2 inhibitors and methods of use thereof
US6919307B2 (en) 2000-11-01 2005-07-19 Praecis Pharmaceuticals, Inc. Therapeutic agents and methods of use thereof for the modulation of angiogenesis
PL366216A1 (en) 2000-11-01 2005-01-24 Praecis Pharmaceuticals Inc. Therapeutic agents and methods of use thereof for the modulation of angiogenesis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2500016A (en) * 1947-04-26 1950-03-07 Canadian Ind Epoxyethylcyclohexane hydroxy ethers

Also Published As

Publication number Publication date
DE68911417T2 (de) 1994-04-14
HUT51265A (en) 1990-04-28
US4954496A (en) 1990-09-04
KR900003163A (ko) 1990-03-23
EP0354767B1 (en) 1993-12-15
DE68911417D1 (de) 1994-01-27
JPH0276866A (ja) 1990-03-16
IE63045B1 (en) 1995-03-22
CA1316921C (en) 1993-04-27
IE892506L (en) 1990-02-12
HU203543B (en) 1991-08-28
JP2811783B2 (ja) 1998-10-15
EP0354767A1 (en) 1990-02-14
KR0130766B1 (ko) 1998-04-09

Similar Documents

Publication Publication Date Title
ES2062011T3 (es) Derivado de ciclohexano.
PT97689A (pt) Processo para a preparacao de composicoes farmaceuticas incorporando como ingrediente activo isoxazol-4-carboxilamida e hidroxialquilideno-cianoacetamida
ATE495793T1 (de) Antitumorzusammensetzungen welche ecteinascidin 743 enthalten
NO308794B1 (no) Farmakologisk aktive pyridin-derivater, preparater inneholdende forbindelsene samt forbindelsenes anvendelse
AR016762A1 (es) Compuestos del acido 4-bromo o 4-yodo fenilamino benzohidroxamico, formulaciones farmaceuticas y uso del mismo
DE19375061I2 (de) Hexadecylphosphocolin enthaltende arzneimittel mit antitumorwirkung.
NO872686D0 (no) Nye farmakologiske forbindelser.
MX9307644A (es) Medicamento que incluye 2-amino-6-n-propil-amino-4,5, 6, 7,-tetrahidrobenzotiazol con efecto antidepresivo.
ES2051753T3 (es) N-(1-azabiciclo(2.2.2)octo-3-il) benzamidas y tiobenzamidas ansioliticas.
ES2130152T3 (es) Medicamentos para tratar dolencias inflamatorias o para analgesia que contienen un nsaid y ranitidina/citrato de bismuto.
ES2038359T3 (es) Procedimiento para la obtencion de formulaciones inyectables intramusculares de inhibidores de girasa.
AR007088A1 (es) 2,4-diaminopirimidinas sustituidas, compuestos intermedios utilizados en su preparacion, procedimiento para la preparacion de dichas 2,4-diaminopirimidinas sustituidas, medicamentos que las contienen y empleos de dichas pirimidinas
KR920002151A (ko) 15-케토-프로스타글란딘 화합물에 의한 염증성 질환 치료
ES2102043T3 (es) Derivados de 22-en-25-oxa en la serie de la vitamina d, procedimiento para su preparacion, preparados farmaceuticos que los contienen, asi como su utilizacion en calidad de medicamentos.
ES2171459T3 (es) Polvo para administracion nasal de farmaco peptidico o proteinaceo.
DK0681473T3 (da) Præparater, der indeholder tandospiron eller dets analoger
KR910009270A (ko) 15-케토-프로스타글란딘 화합물을 이용한 심기능장애의 치료방법
SE7708176L (sv) Bensamidforeningar
ES2053652T3 (es) N-(alquilideno sustituido)-1,2,3,4,-tetrahidro-9-acridinaminas, un procedimiento para su preparacion y su uso como medicamentos.
FR2392668A1 (fr) Medicament a base de coproporphyrine
AR026242A1 (es) Empleo de 2-amino-3,4-dihidro-quinazolinas para la preparacion de un medicamento para el tratamiento o profilaxis de enfermedades provocadas por estadosisquemicos
ES2065855B1 (es) Procedimiento para la preparacion de nuevos derivados desoxiazafosfolipidicos con accion inhibidora de la fosfolipasa a2, nuevos derivados desoxiazafosfolipidicos obtenidos y utilizacion de los mismos.
MX9203068A (es) Compuestos activirales oralmente activos.
ES2144844T3 (es) Derivados ureido biologicamente activos utiles en el tratamiento de la esclerosis en placas.
AR026241A1 (es) Empleo de carbinoles 2-imidazolil substituidos para la preparacion de un medicamento para el tratamiento o profilaxis de enfermedades provocadas porestados isquemicos

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 354767

Country of ref document: ES